Inovio Pharma (NASDAQ: INO) closed its previously announced underwritten public offering of 10,925,000 shares of the Company's common stock, including ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE